Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reovirus sensitizes microsatellite stable colorectal cancer to anti-PD-1 treatment via cross-talk in innate and adaptive immune systems

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.03.458915Source: DataRank Database

Reovirus sensitizes microsatellite stable colorectal cancer to anti-PD-1 treatment via cross-talk in innate and adaptive immune systems is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (19)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Peter John,Tyler Friedman,Jeeshan Jiffry,Hillary Guzik ORCID,Rifat Mannan ORCID

Live enrichment

PubMed:19965766 OpenAlex:https://openalex.org/W3197862624

National Institutes of Health

Grant: 1S10OD019961-01

High-speed/resolution whole slide scanner supported by two core facilities

National Institutes of Health

Grant: 3P30CA013330-39S3

Core Support for Cancer Center

National Institutes of Health

Grant: 1R21AG058027-01

COMPARATIVE EFFECTIVENESS OF BIOLOGIC AGENTS IN ETHNIC MINORITIES WITH COLORECTAL CANCER

green

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/09/04/2021.09.03.458915.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.09.03.458915

repositoryhttps://doi.org/10.1101/2021.09.03.458915

https://dx.doi.org/10.1101/2021.09.03.458915

Fields of Study

Cancer Research and TreatmentsCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

KRASImmune systemBiologyCancer researchOncolytic virusEx vivoColorectal cancerT cellFlow cytometryInnate immune systemCancerImmunologyIn vivo

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being